Results 251 to 260 of about 30,959 (300)

Prescribing variation across Europe: Insights into prescribing practices and educational needs

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1406-1416, May 2026.
Aims Prescribing medication is a complex process, influenced by many factors that can be weighed differently. Four prescriber profiles have been identified: pragmatic‐contextual, guideline‐oriented, experience‐driven and vulnerability‐focused. However, the extent to which European prescribers identify with these profiles and the role of these profiles ...
Mariëlle G. Hartjes   +3 more
wiley   +1 more source

Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stent for In‐Stent Restenosis and De‐Novo Lesions: A Meta‐Analysis of Randomized Controlled Trials

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) are commonly used in percutaneous coronary interventions (PCI), but their long‐term comparative effectiveness remains unclear. This meta‐analysis aimed to compare the clinical and angiographic outcomes of DCB versus DES in patients with in‐stent restenosis (ISR) and
Arman Soltani Moghadam   +19 more
wiley   +1 more source

Soft Tissue Sarcoma Burden and Research Productivity: Global Patterns and Disparities, 1990–2021

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Soft tissue sarcoma (STS) is a rare and diverse type of cancer, with a disproportionate incidence and limited global epidemiological studies. This study aims to analyze the long‐term trends and epidemiological features of the global burden of STS from 1990 to 2021 and to reveal the global research productivity on STS.
Hongjie Pan   +8 more
wiley   +1 more source

Impact of lung cancer screening eligibility criteria on participants' characteristics and healthcare resources

open access: yesInternational Journal of Cancer, Volume 158, Issue 9, Page 2359-2368, 1 May 2026.
What's new? Inclusion criteria for lung cancer screening (LCS) maintain cost control by focusing resources on select high‐risk groups. However, eligible individuals are inherently dissimilar in risk profile and demographics, potentially impacting LCS effectiveness and uptake.
María Olivia Cabrera   +7 more
wiley   +1 more source

Regional Dimension of Participation in Missions Abroad [PDF]

open access: yes, 2011
Kirkovski, Dimitar, Rajkovchevski, Rade
core  

Home - About - Disclaimer - Privacy